|
|
protein activation cascade
|
GO:0072376 |
19 |
0.608
|
Mouse |
|
|
activation of immune response
|
GO:0002253 |
138 |
0.569
|
Mouse |
|
|
regulation of peptidase activity
|
GO:0052547 |
96 |
0.251
|
|
|
|
immune effector process
|
GO:0002252 |
321 |
0.232
|
Mouse |
|
|
complement activation
|
GO:0006956 |
16 |
0.219
|
Mouse |
|
|
regulation of complement activation
|
GO:0030449 |
7 |
0.146
|
|
|
|
extracellular structure organization
|
GO:0043062 |
148 |
0.138
|
|
|
|
extracellular matrix organization
|
GO:0030198 |
147 |
0.127
|
|
|
|
innate immune response
|
GO:0045087 |
157 |
0.123
|
Mouse |
|
|
regulation of cytokine production
|
GO:0001817 |
266 |
0.111
|
|
|
|
humoral immune response
|
GO:0006959 |
57 |
0.105
|
Mouse |
|
|
negative regulation of complement activation
|
GO:0045916 |
3 |
0.102
|
|
|
|
cytokine production
|
GO:0001816 |
319 |
0.093
|
|
|
|
regulation of endopeptidase activity
|
GO:0052548 |
89 |
0.091
|
|
|
|
regulation of proteolysis
|
GO:0030162 |
164 |
0.091
|
|
|
|
protein processing
|
GO:0016485 |
163 |
0.087
|
|
|
|
response to lipopolysaccharide
|
GO:0032496 |
128 |
0.086
|
|
|
|
negative regulation of tooth mineralization
|
GO:0070171 |
1 |
0.084
|
|
|
|
negative regulation of odontogenesis
|
GO:0042483 |
3 |
0.079
|
|
|
|
cell adhesion
|
GO:0007155 |
329 |
0.076
|
|
|
|
oxidation reduction process
|
GO:0055114 |
342 |
0.076
|
|
|
|
negative regulation of proteolysis
|
GO:0045861 |
74 |
0.073
|
|
|
|
negative regulation of protein metabolic process
|
GO:0051248 |
282 |
0.072
|
|
|
|
leukocyte mediated immunity
|
GO:0002443 |
174 |
0.071
|
|
|
|
protein maturation
|
GO:0051604 |
176 |
0.071
|
|
|
|
angiogenesis
|
GO:0001525 |
201 |
0.066
|
|
|
|
adaptive immune response based on somatic recombination of immune receptors built from immunoglobulin superfamily domains
|
GO:0002460 |
145 |
0.066
|
|
|
|
positive regulation of cytokine production
|
GO:0001819 |
174 |
0.065
|
|
|
|
regulation of hydrolase activity
|
GO:0051336 |
246 |
0.062
|
|
|
|
regulation of innate immune response
|
GO:0045088 |
91 |
0.061
|
|
|
|
negative regulation of molecular function
|
GO:0044092 |
258 |
0.057
|
|
|
|
lymphocyte mediated immunity
|
GO:0002449 |
139 |
0.054
|
|
|
|
complement activation lectin pathway
|
GO:0001867 |
5 |
0.054
|
Mouse |
|
|
positive regulation of defense response
|
GO:0031349 |
124 |
0.053
|
|
|
|
negative regulation of cell proliferation
|
GO:0008285 |
296 |
0.053
|
|
|
|
negative regulation of protein activation cascade
|
GO:2000258 |
3 |
0.052
|
|
|
|
response to molecule of bacterial origin
|
GO:0002237 |
143 |
0.052
|
|
|
|
cell substrate adhesion
|
GO:0031589 |
130 |
0.049
|
|
|
|
wound healing
|
GO:0042060 |
157 |
0.046
|
|
|
|
biomineral tissue development
|
GO:0031214 |
64 |
0.045
|
|
|
|
production of molecular mediator of immune response
|
GO:0002440 |
103 |
0.044
|
|
|
|
glycoprotein metabolic process
|
GO:0009100 |
116 |
0.044
|
|
|
|
chondroitin sulfate proteoglycan metabolic process
|
GO:0050654 |
20 |
0.044
|
|
|
|
urogenital system development
|
GO:0001655 |
261 |
0.043
|
|
|
|
cellular response to cytokine stimulus
|
GO:0071345 |
189 |
0.042
|
|
|
|
cellular amine metabolic process
|
GO:0044106 |
44 |
0.041
|
|
|
|
regulation of inflammatory response
|
GO:0050727 |
147 |
0.040
|
|
|
|
small gtpase mediated signal transduction
|
GO:0007264 |
97 |
0.040
|
|
|
|
positive regulation of protein modification process
|
GO:0031401 |
299 |
0.040
|
|
|
|
sulfur compound metabolic process
|
GO:0006790 |
100 |
0.038
|
|
|
|
cytokine mediated signaling pathway
|
GO:0019221 |
115 |
0.037
|
|
|
|
cellular response to molecule of bacterial origin
|
GO:0071219 |
83 |
0.037
|
|
|
|
proteoglycan metabolic process
|
GO:0006029 |
38 |
0.036
|
|
|
|
cation transport
|
GO:0006812 |
399 |
0.035
|
|
|
|
collagen fibril organization
|
GO:0030199 |
32 |
0.035
|
|
|
|
defense response to other organism
|
GO:0098542 |
197 |
0.034
|
|
|
|
regulation of vasculature development
|
GO:1901342 |
88 |
0.032
|
|
|
|
regulation of cell adhesion
|
GO:0030155 |
154 |
0.032
|
|
|
|
negative regulation of endopeptidase activity
|
GO:0010951 |
44 |
0.032
|
|
|
|
kidney development
|
GO:0001822 |
213 |
0.032
|
|
|
|
transmembrane transport
|
GO:0055085 |
412 |
0.031
|
|
|
|
defense response to bacterium
|
GO:0042742 |
119 |
0.031
|
|
|
|
negative regulation of hydrolase activity
|
GO:0051346 |
71 |
0.031
|
|
|
|
negative regulation of cellular protein metabolic process
|
GO:0032269 |
247 |
0.031
|
|
|
|
cellular response to growth factor stimulus
|
GO:0071363 |
197 |
0.031
|
|
|
|
regulation of cell migration
|
GO:0030334 |
219 |
0.031
|
|
|
|
cellular lipid metabolic process
|
GO:0044255 |
323 |
0.030
|
|
|
|
activation of membrane attack complex
|
GO:0001905 |
4 |
0.030
|
|
|
|
sterol metabolic process
|
GO:0016125 |
58 |
0.029
|
|
|
|
transmembrane receptor protein serine threonine kinase signaling pathway
|
GO:0007178 |
194 |
0.029
|
|
|
|
mucopolysaccharide metabolic process
|
GO:1903510 |
25 |
0.028
|
|
|
|
blood vessel morphogenesis
|
GO:0048514 |
285 |
0.028
|
|
|
|
protein import into nucleus
|
GO:0006606 |
95 |
0.028
|
|
|
|
regulation of protein processing
|
GO:0070613 |
96 |
0.028
|
|
|
|
tissue remodeling
|
GO:0048771 |
102 |
0.027
|
|
|
|
cellular ketone metabolic process
|
GO:0042180 |
84 |
0.027
|
|
|
|
anatomical structure homeostasis
|
GO:0060249 |
145 |
0.027
|
|
|
|
positive regulation of activation of membrane attack complex
|
GO:0001970 |
2 |
0.027
|
|
|
|
regulation of acute inflammatory response
|
GO:0002673 |
27 |
0.027
|
|
|
|
regulation of response to wounding
|
GO:1903034 |
189 |
0.027
|
|
|
|
transmembrane receptor protein tyrosine kinase signaling pathway
|
GO:0007169 |
247 |
0.027
|
|
|
|
regulation of angiogenesis
|
GO:0045765 |
81 |
0.027
|
|
|
|
regulation of cellular ketone metabolic process
|
GO:0010565 |
66 |
0.027
|
|
|
|
mapk cascade
|
GO:0000165 |
281 |
0.027
|
|
|
|
regulation of ras protein signal transduction
|
GO:0046578 |
114 |
0.026
|
|
|
|
cytoplasmic transport
|
GO:0016482 |
234 |
0.026
|
|
|
|
regulation of cellular amine metabolic process
|
GO:0033238 |
20 |
0.026
|
|
|
|
positive regulation of peptidase activity
|
GO:0010952 |
49 |
0.026
|
|
|
|
positive regulation of cellular amine metabolic process
|
GO:0033240 |
5 |
0.026
|
|
|
|
chondroitin sulfate metabolic process
|
GO:0030204 |
17 |
0.026
|
|
|
|
amine metabolic process
|
GO:0009308 |
45 |
0.025
|
|
|
|
regulation of adaptive immune response
|
GO:0002819 |
90 |
0.025
|
|
|
|
peptidyl amino acid modification
|
GO:0018193 |
336 |
0.025
|
|
|
|
nucleoside phosphate metabolic process
|
GO:0006753 |
338 |
0.025
|
|
|
|
response to growth factor
|
GO:0070848 |
198 |
0.025
|
|
|
|
gland development
|
GO:0048732 |
330 |
0.024
|
|
|
|
epithelial cell proliferation
|
GO:0050673 |
174 |
0.024
|
|
|
|
macromolecule catabolic process
|
GO:0009057 |
281 |
0.024
|
|
|
|
carbohydrate homeostasis
|
GO:0033500 |
128 |
0.024
|
|
|
|
positive regulation of cellular amino acid metabolic process
|
GO:0045764 |
3 |
0.024
|
|
|
|
regulation of defense response
|
GO:0031347 |
233 |
0.023
|
|
|
|
carbohydrate metabolic process
|
GO:0005975 |
230 |
0.023
|
|
|
|
circulatory system process
|
GO:0003013 |
197 |
0.023
|
|
|
|
fat cell differentiation
|
GO:0045444 |
160 |
0.023
|
|
|
|
regulation of tooth mineralization
|
GO:0070170 |
2 |
0.023
|
|
|
|
regulation of lymphocyte mediated immunity
|
GO:0002706 |
84 |
0.022
|
|
|
|
regulation of kinase activity
|
GO:0043549 |
249 |
0.022
|
|
|
|
rho protein signal transduction
|
GO:0007266 |
32 |
0.022
|
|
|
|
regulation of cell activation
|
GO:0050865 |
289 |
0.022
|
|
|
|
antibacterial peptide biosynthetic process
|
GO:0002780 |
2 |
0.022
|
|
|
|
response to acid chemical
|
GO:0001101 |
111 |
0.022
|
|
|
|
regulation of adaptive immune response based on somatic recombination of immune receptors built from immunoglobulin superfamily domains
|
GO:0002822 |
87 |
0.022
|
|
|
|
positive regulation of immune effector process
|
GO:0002699 |
107 |
0.022
|
|
|
|
blood circulation
|
GO:0008015 |
195 |
0.021
|
|
|
|
response to interferon gamma
|
GO:0034341 |
34 |
0.021
|
|
|
|
cellular response to organonitrogen compound
|
GO:0071417 |
145 |
0.021
|
|
|
|
nucleotide metabolic process
|
GO:0009117 |
332 |
0.021
|
|
|
|
ras protein signal transduction
|
GO:0007265 |
77 |
0.021
|
|
|
|
reactive oxygen species biosynthetic process
|
GO:1903409 |
8 |
0.021
|
|
|
|
negative regulation of phosphorus metabolic process
|
GO:0010563 |
184 |
0.020
|
|
|
|
regulation of protein activation cascade
|
GO:2000257 |
7 |
0.020
|
|
|
|
negative regulation of epithelial cell proliferation
|
GO:0050680 |
64 |
0.020
|
|
|
|
reactive oxygen species metabolic process
|
GO:0072593 |
84 |
0.020
|
|
|
|
cartilage development
|
GO:0051216 |
140 |
0.020
|
|
|
|
response to steroid hormone
|
GO:0048545 |
56 |
0.020
|
|
|
|
aromatic compound catabolic process
|
GO:0019439 |
286 |
0.020
|
|
|
|
respiratory system development
|
GO:0060541 |
190 |
0.019
|
|
|
|
peptide metabolic process
|
GO:0006518 |
46 |
0.019
|
|
|
|
nucleoside phosphate catabolic process
|
GO:1901292 |
222 |
0.019
|
|
|
|
negative regulation of protein maturation
|
GO:1903318 |
79 |
0.019
|
|
|
|
lipid biosynthetic process
|
GO:0008610 |
179 |
0.019
|
|
|
|
connective tissue development
|
GO:0061448 |
179 |
0.019
|
|
|
|
regulation of glucose metabolic process
|
GO:0010906 |
60 |
0.019
|
|
|
|
positive regulation of protein phosphorylation
|
GO:0001934 |
242 |
0.019
|
|
|
|
negative regulation of peptidase activity
|
GO:0010466 |
46 |
0.019
|
|
|
|
organic cyclic compound catabolic process
|
GO:1901361 |
295 |
0.019
|
|
|
|
camera type eye development
|
GO:0043010 |
266 |
0.019
|
|
|
|
regulation of blood pressure
|
GO:0008217 |
93 |
0.019
|
|
|
|
inorganic ion transmembrane transport
|
GO:0098660 |
234 |
0.019
|
|
|
|
t cell activation
|
GO:0042110 |
289 |
0.019
|
|
|
|
positive regulation of protein kinase activity
|
GO:0045860 |
144 |
0.018
|
|
|
|
regulation of system process
|
GO:0044057 |
200 |
0.018
|
|
|
|
phagocytosis
|
GO:0006909 |
66 |
0.018
|
|
|
|
regulation of apoptotic signaling pathway
|
GO:2001233 |
197 |
0.018
|
|
|
|
fatty acid metabolic process
|
GO:0006631 |
121 |
0.018
|
|
|
|
regulation of epithelial cell proliferation
|
GO:0050678 |
141 |
0.018
|
|
|
|
physiological muscle hypertrophy
|
GO:0003298 |
3 |
0.018
|
|
|
|
negative regulation of protein processing
|
GO:0010955 |
79 |
0.018
|
|
|
|
cellular response to biotic stimulus
|
GO:0071216 |
92 |
0.018
|
|
|
|
positive regulation of cell substrate adhesion
|
GO:0010811 |
47 |
0.018
|
|
|
|
negative regulation of immune system process
|
GO:0002683 |
209 |
0.018
|
|
|
|
nitrogen compound transport
|
GO:0071705 |
271 |
0.018
|
|
|
|
transforming growth factor beta receptor signaling pathway
|
GO:0007179 |
71 |
0.018
|
|
|
|
iron ion import into cell
|
GO:0097459 |
4 |
0.017
|
|
|
|
positive regulation of apoptotic cell clearance
|
GO:2000427 |
3 |
0.017
|
|
|
|
transition metal ion transport
|
GO:0000041 |
38 |
0.017
|
|
|
|
cellular response to lipopolysaccharide
|
GO:0071222 |
77 |
0.017
|
|
|
|
cellular response to lipid
|
GO:0071396 |
145 |
0.017
|
|
|
|
heterocycle catabolic process
|
GO:0046700 |
280 |
0.017
|
|
|
|
cellular amino acid metabolic process
|
GO:0006520 |
103 |
0.017
|
|
|
|
regulation of systemic arterial blood pressure mediated by a chemical signal
|
GO:0003044 |
33 |
0.017
|
|
|
|
triglyceride metabolic process
|
GO:0006641 |
51 |
0.017
|
|
|
|
monocarboxylic acid metabolic process
|
GO:0032787 |
191 |
0.017
|
|
|
|
regulation of hormone levels
|
GO:0010817 |
211 |
0.017
|
|
|
|
regulation of secretion by cell
|
GO:1903530 |
249 |
0.017
|
|
|
|
negative regulation of transforming growth factor beta receptor signaling pathway
|
GO:0030512 |
26 |
0.017
|
|
|
|
response to oxidative stress
|
GO:0006979 |
123 |
0.016
|
|
|
|
response to organic cyclic compound
|
GO:0014070 |
198 |
0.016
|
Rat |
|
|
inflammatory response
|
GO:0006954 |
244 |
0.016
|
|
|
|
regulation of mapk cascade
|
GO:0043408 |
248 |
0.016
|
|
|
|
positive regulation of endocytosis
|
GO:0045807 |
42 |
0.016
|
|
|
|
regulation of blood vessel size
|
GO:0050880 |
56 |
0.016
|
|
|
|
ion transmembrane transport
|
GO:0034220 |
361 |
0.016
|
|
|
|
homeostasis of number of cells
|
GO:0048872 |
210 |
0.016
|
|
|
|
positive regulation of protein kinase b signaling
|
GO:0051897 |
32 |
0.016
|
|
|
|
positive regulation of adaptive immune response based on somatic recombination of immune receptors built from immunoglobulin superfamily domains
|
GO:0002824 |
61 |
0.016
|
|
|
|
monosaccharide metabolic process
|
GO:0005996 |
106 |
0.016
|
|
|
|
regulation of reactive oxygen species metabolic process
|
GO:2000377 |
40 |
0.016
|
|
|
|
apoptotic signaling pathway
|
GO:0097190 |
306 |
0.016
|
|
|
|
sensory system development
|
GO:0048880 |
3 |
0.016
|
|
|
|
cytokine production involved in immune response
|
GO:0002367 |
34 |
0.016
|
|
|
|
cellular macromolecule catabolic process
|
GO:0044265 |
206 |
0.015
|
|
|
|
muscle tissue development
|
GO:0060537 |
308 |
0.015
|
|
|
|
organonitrogen compound biosynthetic process
|
GO:1901566 |
192 |
0.015
|
|
|
|
regulation of reactive oxygen species biosynthetic process
|
GO:1903426 |
2 |
0.015
|
|
|
|
regulation of cellular catabolic process
|
GO:0031329 |
242 |
0.015
|
|
|
|
negative regulation of phosphorylation
|
GO:0042326 |
166 |
0.015
|
|
|
|
regulation of cellular response to stress
|
GO:0080135 |
159 |
0.015
|
|
|
|
protein modification by small protein conjugation or removal
|
GO:0070647 |
207 |
0.015
|
|
|
|
multicellular organismal homeostasis
|
GO:0048871 |
164 |
0.015
|
|
|
|
regulation of secretion
|
GO:0051046 |
274 |
0.015
|
|
|
|
negative regulation of immune effector process
|
GO:0002698 |
55 |
0.015
|
|
|
|
muscle cell differentiation
|
GO:0042692 |
261 |
0.015
|
|
|
|
positive regulation of reactive oxygen species biosynthetic process
|
GO:1903428 |
2 |
0.015
|
|
|
|
respiratory tube development
|
GO:0030323 |
167 |
0.015
|
|
|
|
peptide cross linking
|
GO:0018149 |
10 |
0.015
|
|
|
|
regulation of fatty acid biosynthetic process
|
GO:0042304 |
12 |
0.015
|
|
|
|
positive regulation of kinase activity
|
GO:0033674 |
155 |
0.014
|
|
|
|
nucleoside triphosphate metabolic process
|
GO:0009141 |
230 |
0.014
|
|
|
|
cation transmembrane transport
|
GO:0098655 |
266 |
0.014
|
|
|
|
positive regulation of innate immune response
|
GO:0045089 |
80 |
0.014
|
|
|
|
renal system development
|
GO:0072001 |
225 |
0.014
|
|
|
|
organ growth
|
GO:0035265 |
117 |
0.014
|
|
|
|
regulation of toll like receptor 4 signaling pathway
|
GO:0034143 |
4 |
0.014
|
|
|
|
negative regulation of cellular component organization
|
GO:0051129 |
194 |
0.014
|
|
|
|
cellular response to hormone stimulus
|
GO:0032870 |
150 |
0.014
|
|
|
|
regulation of systemic arterial blood pressure
|
GO:0003073 |
61 |
0.014
|
|
|
|
spermatogenesis
|
GO:0007283 |
284 |
0.014
|
|
|
|
cellular nitrogen compound catabolic process
|
GO:0044270 |
280 |
0.014
|
|
|
|
purine nucleoside triphosphate catabolic process
|
GO:0009146 |
203 |
0.014
|
|
|
|
lymphocyte proliferation
|
GO:0046651 |
164 |
0.014
|
|
|
|
positive regulation of cell activation
|
GO:0050867 |
158 |
0.014
|
|
|
|
cell type specific apoptotic process
|
GO:0097285 |
268 |
0.014
|
|
|
|
morphogenesis of a branching epithelium
|
GO:0061138 |
193 |
0.014
|
|
|
|
glucose transport
|
GO:0015758 |
56 |
0.014
|
|
|
|
nucleobase containing small molecule metabolic process
|
GO:0055086 |
352 |
0.014
|
|
|
|
ribose phosphate metabolic process
|
GO:0019693 |
291 |
0.014
|
|
|
|
regulation of fat cell differentiation
|
GO:0045598 |
81 |
0.014
|
|
|
|
positive regulation of glucose transport
|
GO:0010828 |
16 |
0.014
|
|
|
|
regulation of glucose transport
|
GO:0010827 |
32 |
0.014
|
|
|
|
glucose homeostasis
|
GO:0042593 |
128 |
0.014
|
|
|
|
response to decreased oxygen levels
|
GO:0036293 |
59 |
0.013
|
|
|
|
activation of innate immune response
|
GO:0002218 |
56 |
0.013
|
|
|
|
prostate gland development
|
GO:0030850 |
48 |
0.013
|
|
|
|
positive regulation of cell adhesion
|
GO:0045785 |
80 |
0.013
|
|
|
|
monocarboxylic acid biosynthetic process
|
GO:0072330 |
61 |
0.013
|
|
|
|
response to radiation
|
GO:0009314 |
165 |
0.013
|
|
|
|
multicellular organismal macromolecule metabolic process
|
GO:0044259 |
19 |
0.013
|
|
|
|
regulation of neuron differentiation
|
GO:0045664 |
281 |
0.013
|
|
|
|
monosaccharide transport
|
GO:0015749 |
58 |
0.013
|
|
|
|
regulation of lymphocyte proliferation
|
GO:0050670 |
117 |
0.013
|
|
|
|
regulation of odontogenesis
|
GO:0042481 |
18 |
0.013
|
|
|
|
regulation of carbohydrate metabolic process
|
GO:0006109 |
75 |
0.013
|
|
|
|
epidermis development
|
GO:0008544 |
187 |
0.013
|
|
|
|
regulation of lipid metabolic process
|
GO:0019216 |
118 |
0.013
|
|
|
|
lateral line system development
|
GO:0048925 |
1 |
0.013
|
|
|
|
positive regulation of hydrolase activity
|
GO:0051345 |
148 |
0.013
|
|
|
|
interleukin 1 production
|
GO:0032612 |
31 |
0.013
|
|
|
|
organic hydroxy compound metabolic process
|
GO:1901615 |
203 |
0.013
|
|
|
|
immunoglobulin mediated immune response
|
GO:0016064 |
69 |
0.013
|
|
|
|
cell matrix adhesion
|
GO:0007160 |
68 |
0.013
|
|
|
|
leukocyte migration
|
GO:0050900 |
124 |
0.013
|
|
|
|
glycosaminoglycan metabolic process
|
GO:0030203 |
34 |
0.013
|
|
|
|
posttranscriptional regulation of gene expression
|
GO:0010608 |
155 |
0.013
|
|
|
|
negative regulation of growth
|
GO:0045926 |
99 |
0.013
|
|
|
|
positive regulation of programmed cell death
|
GO:0043068 |
218 |
0.013
|
|
|
|
peptidyl tyrosine modification
|
GO:0018212 |
145 |
0.013
|
|
|
|
leukocyte chemotaxis
|
GO:0030595 |
69 |
0.013
|
|
|
|
proteolysis involved in cellular protein catabolic process
|
GO:0051603 |
147 |
0.013
|
|
|
|
epithelial tube morphogenesis
|
GO:0060562 |
303 |
0.013
|
|
|
|
protein catabolic process
|
GO:0030163 |
221 |
0.013
|
|
|
|
regulation of cellular component biogenesis
|
GO:0044087 |
181 |
0.013
|
|
|
|
positive regulation of apoptotic process
|
GO:0043065 |
217 |
0.013
|
|
|
|
glycerolipid metabolic process
|
GO:0046486 |
122 |
0.013
|
|
|
|
immune response activating signal transduction
|
GO:0002757 |
116 |
0.013
|
|
|
|
positive regulation of nervous system development
|
GO:0051962 |
221 |
0.013
|
|
|
|
female sex differentiation
|
GO:0046660 |
84 |
0.013
|
|
|
|
lung development
|
GO:0030324 |
164 |
0.013
|
|
|
|
positive regulation of proteolysis
|
GO:0045862 |
85 |
0.013
|
|
|
|
endocytosis
|
GO:0006897 |
168 |
0.012
|
|
|
|
regulation of leukocyte mediated immunity
|
GO:0002703 |
104 |
0.012
|
|
|
|
regulation of protein transport
|
GO:0051223 |
163 |
0.012
|
|
|
|
anion transport
|
GO:0006820 |
177 |
0.012
|
|
|
|
positive regulation of cell death
|
GO:0010942 |
224 |
0.012
|
|
|
|
cellularization
|
GO:0007349 |
1 |
0.012
|
|
|
|
chemotaxis
|
GO:0006935 |
247 |
0.012
|
|
|
|
skeletal system development
|
GO:0001501 |
356 |
0.012
|
|
|
|
response to peptide
|
GO:1901652 |
136 |
0.012
|
|
|
|
organic acid biosynthetic process
|
GO:0016053 |
86 |
0.012
|
|
|
|
t cell mediated cytotoxicity
|
GO:0001913 |
26 |
0.012
|
|
|
|
male gamete generation
|
GO:0048232 |
285 |
0.012
|
|
|
|
skeletal system morphogenesis
|
GO:0048705 |
203 |
0.012
|
|
|
|
neuron death
|
GO:0070997 |
154 |
0.012
|
|
|
|
regulation of establishment of protein localization
|
GO:0070201 |
181 |
0.012
|
|
|
|
bone development
|
GO:0060348 |
120 |
0.012
|
|
|
|
regulation of removal of superoxide radicals
|
GO:2000121 |
4 |
0.012
|
|
|
|
positive regulation of inflammatory response
|
GO:0050729 |
47 |
0.012
|
|
|
|
regulation of cellular amino acid metabolic process
|
GO:0006521 |
5 |
0.012
|
|
|
|
cell cell adhesion
|
GO:0098609 |
41 |
0.012
|
|
|
|
nuclear transport
|
GO:0051169 |
139 |
0.012
|
|
|
|
lymphocyte activation involved in immune response
|
GO:0002285 |
93 |
0.012
|
|
|
|
cellular carbohydrate metabolic process
|
GO:0044262 |
119 |
0.012
|
|
|
|
regulation of anatomical structure size
|
GO:0090066 |
178 |
0.012
|
|
|
|
synapse organization
|
GO:0050808 |
125 |
0.012
|
|
|
|
cellular protein catabolic process
|
GO:0044257 |
155 |
0.012
|
|
|
|
peptidyl serine modification
|
GO:0018209 |
83 |
0.012
|
|
|
|
peptide cross linking via chondroitin 4 sulfate glycosaminoglycan
|
GO:0019800 |
8 |
0.012
|
|
|
|
leukocyte mediated cytotoxicity
|
GO:0001909 |
62 |
0.012
|
|
|
|
response to transforming growth factor beta
|
GO:0071559 |
88 |
0.012
|
|
|
|
physiological cardiac muscle hypertrophy
|
GO:0003301 |
3 |
0.012
|
|
|
|
negative regulation of fat cell differentiation
|
GO:0045599 |
36 |
0.012
|
|
|
|
negative regulation of transmembrane receptor protein serine threonine kinase signaling pathway
|
GO:0090101 |
61 |
0.012
|
|
|
|
negative regulation of defense response
|
GO:0031348 |
77 |
0.012
|
|
|
|
multicellular organismal signaling
|
GO:0035637 |
91 |
0.011
|
|
|
|
protein localization to organelle
|
GO:0033365 |
185 |
0.011
|
|
|
|
regulation of cell projection organization
|
GO:0031344 |
206 |
0.011
|
|
|
|
inorganic cation transmembrane transport
|
GO:0098662 |
207 |
0.011
|
|
|
|
cellular homeostasis
|
GO:0019725 |
240 |
0.011
|
|
|
|
cofactor metabolic process
|
GO:0051186 |
80 |
0.011
|
|
|
|
regulation of transforming growth factor beta receptor signaling pathway
|
GO:0017015 |
43 |
0.011
|
|
|
|
erk1 and erk2 cascade
|
GO:0070371 |
77 |
0.011
|
|
|
|
transmission of nerve impulse
|
GO:0019226 |
76 |
0.011
|
|
|
|
positive regulation of chemotaxis
|
GO:0050921 |
38 |
0.011
|
|
|
|
regulation of protein secretion
|
GO:0050708 |
82 |
0.011
|
|
|
|
type b pancreatic cell proliferation
|
GO:0044342 |
10 |
0.011
|
|
|
|
striated muscle tissue development
|
GO:0014706 |
293 |
0.011
|
|
|
|
hexose transport
|
GO:0008645 |
56 |
0.011
|
|
|
|
cell activation involved in immune response
|
GO:0002263 |
126 |
0.011
|
|
|
|
autophagy
|
GO:0006914 |
45 |
0.011
|
|
|
|
renal system process
|
GO:0003014 |
48 |
0.011
|
|
|
|
divalent inorganic cation transport
|
GO:0072511 |
178 |
0.011
|
|
|
|
carboxylic acid biosynthetic process
|
GO:0046394 |
86 |
0.011
|
|
|
|
regulation of cellular response to growth factor stimulus
|
GO:0090287 |
82 |
0.011
|
|
|
|
cellular response to steroid hormone stimulus
|
GO:0071383 |
33 |
0.011
|
|
|
|
positive regulation of cytokine secretion
|
GO:0050715 |
41 |
0.011
|
|
|
|
negative regulation of protein modification process
|
GO:0031400 |
163 |
0.011
|
|
|
|
cell growth
|
GO:0016049 |
130 |
0.011
|
|
|
|
small molecule biosynthetic process
|
GO:0044283 |
132 |
0.011
|
|
|
|
cellular chemical homeostasis
|
GO:0055082 |
215 |
0.011
|
|
|
|
regulation of blood vessel size by renin angiotensin
|
GO:0002034 |
5 |
0.011
|
|
|
|
protein targeting
|
GO:0006605 |
143 |
0.011
|
|
|
|
protein kinase b signaling
|
GO:0043491 |
74 |
0.011
|
|
|
|
regulation of humoral immune response
|
GO:0002920 |
22 |
0.011
|
|
|
|
regulation of lymphocyte activation
|
GO:0051249 |
240 |
0.011
|
|
|
|
skin development
|
GO:0043588 |
220 |
0.010
|
|
|
|
carboxylic acid transport
|
GO:0046942 |
100 |
0.010
|
|
|
|
macromolecule glycosylation
|
GO:0043413 |
55 |
0.010
|
|
|
|
carbohydrate transport
|
GO:0008643 |
62 |
0.010
|
|
|
|
regulation of body fluid levels
|
GO:0050878 |
162 |
0.010
|
|
|
|
microtubule based process
|
GO:0007017 |
236 |
0.010
|
|
|
|
iron ion homeostasis
|
GO:0055072 |
36 |
0.010
|
|
|
|
metal ion homeostasis
|
GO:0055065 |
189 |
0.010
|
|
|
|
ribonucleotide metabolic process
|
GO:0009259 |
291 |
0.010
|
|
|
|
positive regulation of response to wounding
|
GO:1903036 |
66 |
0.010
|
|
|
|
response to oxygen levels
|
GO:0070482 |
62 |
0.010
|
|
|
|
carbohydrate derivative biosynthetic process
|
GO:1901137 |
183 |
0.010
|
|
|
|
regulation of transmembrane receptor protein serine threonine kinase signaling pathway
|
GO:0090092 |
112 |
0.010
|
|
|
|
hexose biosynthetic process
|
GO:0019319 |
39 |
0.010
|
|
|
|
lipid catabolic process
|
GO:0016042 |
69 |
0.010
|
|
|
|
positive regulation of lymphocyte activation
|
GO:0051251 |
140 |
0.010
|
|
|
|
purine nucleotide metabolic process
|
GO:0006163 |
302 |
0.010
|
|
|
|
endocrine process
|
GO:0050886 |
39 |
0.010
|
|
|
|
regulation of organelle organization
|
GO:0033043 |
289 |
0.010
|
|
|
|
fatty acid biosynthetic process
|
GO:0006633 |
41 |
0.010
|
|
|
|
positive regulation of protein activation cascade
|
GO:2000259 |
2 |
0.010
|
|
|
|
regulation of cell growth involved in cardiac muscle cell development
|
GO:0061050 |
3 |
0.010
|
|